Dr. Ashraf Ibrahim is a professor of medicine and an infectious diseases specialist at Harbor-UCLA Medical Center and LA BioMed. His research focuses on advancing the understanding of the pathogenic mechanisms and virulence factors of fungal and bacterial infections, and on translating this knowledge into novel strategies to combat infectious diseases.
Read more »
- Professor, Division of Infectious Diseases, David Geffen School of Medicine at Harbor-UCLA Medical Center
- Investigator, LA BioMed
AWARDS & RECOGNITIONS
- Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Program Committee Award, Therapy and Prevention of Microbial Disease, 2011
Recent and/or Significant Studies:
Cloning and characterization of Rhizopus oryzae high affinity iron permease gene (rFTR1).
Fu Y, H Lee, M Collins, H-F Tsai, B Spellberg, JE Edwards Jr., J Kwon-Chung, AS Ibrahim. 2004.
FEMS Microbiol Lett In press.
A novel inhalational murine model of invasive pulmonary aspergillosis.
Sheppard DC, G Rieg, LY Chiang, SG Filler, JE Edwards Jr., AS Ibrahim. 2004.
Antimicrob Agents Chemother. 48:1908-1911.
Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae.
Ibrahim AS, V Avanessian, BJ Spellberg, JE Edwards Jr. 2003.
Antimicrob Agents Chemother 47:3343-3344.